A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
Clinical trial NCT05622708 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05622708
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2028-02-08
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.